Report of the GUDID Clinically Relevant Size (CRS) Work Group

By AHRMM

Related Resources

Advisory
The FDA UDI ruling has finally arrived - the proposed rule has published.
White Papers
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the s
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Issue Brief
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.